SCHEMBL29307904

SCHEMBL29307904

COc1cc2c(cc1OC)c1c(cc(OC)c3oc(-c4ccccc4F)nc31)c1cc(OC)c3oc(-c4ccccc4F)nc3c21

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 5/20 0.47
▸ MEN1 O00255 4/20 0.47
▸ KMT2A Q03164 4/20 0.47
▸ SMN1; SMN2 Q16637 2/20 0.47
▸ ALDH1A1 P00352 2/20 0.47
▸ LMNA P02545 2/20 0.47
▸ NPSR1 Q6W5P4 1/20 0.47
▸ CYP1A1 P04798 2/20 0.46
▸ CYP1A2 P05177 2/20 0.46
▸ CYP1B1 Q16678 2/20 0.46
▸ NPC1 O15118 2/20 0.44
▸ HTT P42858 2/20 0.44
▸ RPS6KA2 Q15349 1/20 0.42
▸ ESR1 P03372 1/20 0.42
▸ ESR2 Q92731 1/20 0.42
▸ CTSG P08311 3/20 0.42
▸ KLK7 P49862 3/20 0.42
▸ KLK14 Q9P0G3 3/20 0.42
▸ KLK5 Q9Y337 3/20 0.42
▸ TP53 P04637 3/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29307851 0.99 MAPT (0.46) MAPTMEN1KMT2ASMN1; SMN2ALDH1A1
SCHEMBL29307867 0.84 KLK7 (0.51) MAPTMEN1KMT2ASMN1; SMN2ALDH1A1
SCHEMBL29307903 0.84 MAPT (0.46) MAPTMEN1KMT2ASMN1; SMN2LMNA
SCHEMBL29307866 0.84 KLK7 (0.58) MEN1KMT2AHTTCTSGKLK7
SCHEMBL29307868 0.84 KMT2A (0.42) MAPTMEN1KMT2ASMN1; SMN2ALDH1A1
SCHEMBL29307845 0.84 ALDH1A1 (0.42) MAPTMEN1KMT2ASMN1; SMN2ALDH1A1
SCHEMBL29307783 0.80 KDM4E (0.39) MAPTMEN1KMT2AALDH1A1LMNA
SCHEMBL29307843 0.80 NPC1 (0.47) MAPTMEN1KMT2ASMN1; SMN2ALDH1A1
SCHEMBL29307849 0.78 ESR1 (0.48) MAPTMEN1KMT2ASMN1; SMN2ALDH1A1
SCHEMBL29307850 0.78 PDGFRB (0.47) MAPTALDH1A1CYP1A1CYP1A2CYP1B1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12041850-B2 Luminescent compounds Chromatwist Limited (GB) 2024-07-16 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12041850-B2 Luminescent compounds AHR, ARNT, CYCS MAPT 4531/4885MEN1 2802/4885KMT2A 1876/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback